It must be emphasized that lifestyle modification (i.e., adhering to a heart healthy diet, regular exercise
habits, avoidance of tobacco products, and maintenance of a healthy weight) remains a critical component
of health promotion and ASCVD risk reduction, both prior to and in concert with the use of cholesterol lowering
drug therapies. Healthy diet or lifestyle modifications were recommended as background therapy
for the RCTs of cholesterol-lowering drug therapy. See the 2013 Lifestyle Management Work Group
Guideline (10) for lifestyle recommendations for healthy adults.